… Oxaliplatin (OXA)- and 5-fluorouracil (5-Fu)-based chemotherapies are commonly employed as … Vymetalkova V. 5-fluorouracil and other fluoropyrimidines in colorectal cancer: past, present … B to promote cancer metastasis and chemoresistance. Cancer Cell. 2022;40 …

… -PEG polymers to deliver 5-fluorouracil (5-FU), achieved a threefold increase … apoptosis for enhanced colorectal cancer chemo-photothermal therapy. J Nanobiotechnol. … -selectin to enhance chemoradiotherapy in murine colorectal cancer. Cancer Lett. 2021;500 …

… mRNA stability and chemoresistance in triple-negative breast cancer. Redox Biol. 2024 … . Sec62 promotes stemness and chemoresistance of human colorectal cancer through activating Wnt … JS, et al. 5-FU promotes stemness of colorectal cancer via p53-mediated …

… fluorouracil known as 5-FU. Oral chemotherapy tablet Capecitabine. … the first chemotherapy treatment. Newer cancer drugs sometimes … before dosing patients with 5-FU or capecitabine. However … 5-FU and capecitabine are still powerful tools against many cancers …

… 007567) evaluating adjuvant platinum-based chemotherapy plus 5-Fluorouracil (5-FU) vs adjuvant platinum-based … , Illinois.1 “Globally, penile cancer is rare. However, countries like … plus 5-FU to platinum-paclitaxel in high-risk penile cancer,” explained …

… patients with stage III colon cancer and detectable ctDNA following … options included: No chemotherapy to 5-fluorouracil (5-FU) and capecitabine; 5-FU/capecitabine to … -guided adjuvant chemotherapy escalation in stage III colon cancer: primary analysis …

… with or without chemotherapy (oxaliplatin and leucovorin plus 5-fluorouracil [mFOLFOX6]). For … plus oxaliplatin) or FP (5-FU plus cisplatin) and included pneumonitis … require urgent cytoreductive therapy. Urothelial Cancer KEYTRUDA, in combination with …

… for anal cancer has evolved from surgery to combined chemoradiation, enabling preservation … combination of mitomycin C (MMC), 5-fluorouracil (5-FU), and radiotherapy (RT) without these …

… says pancreatic cancer is challenging to treat because of chemotherapy resistance caused … over-expressed in pancreatic cancer. Most cancer treatments are designed to … of folinic acid (leucovorin), fluorouracil (5-FU), irinotecan and oxaliplatin and is …

… therapies can help overcome this chemoresistance – bevacizumab improves cisplatin … the irinotecan, temsirolimus, topotecan, 5-Fluorouracil, paclitaxel, and piperlongumine were commonly … FGD5-AS1 promotes 5-Fu resistance of cervical cancer cells through …